Patents
Patents for C07C 229 - Compounds containing amino and carboxyl groups bound to the same carbon skeleton (21,416)
08/2002
08/28/2002EP1019363B1 Process for the preparation of an inorganic salt of an optically active phenylglycine derivative
08/28/2002EP0946093B1 Fungicidal compositions based on (n-phenylacetyl-n-2,6-xylyl)methyl alaninate
08/28/2002EP0729344B1 Active substance delivery system
08/28/2002CN1365967A Amine derivative with K channel regulation function and its preparing process and application
08/28/2002CN1365966A Amine derivative for preventing ischemic and anoxia damage of nerve and its medical application
08/28/2002CN1089786C 偶氮染料混合物 Azo dye mixture
08/27/2002US6441167 Cinoxacin lanthanide chelates and their use as biomolecular probes
08/27/2002US6441049 Administering compound effective to inhibit binding of an amyloid beta peptide with alpha-7 nicotinic acetylcholine receptors
08/27/2002US6440667 Analysis of target molecules using an encoding system
08/27/2002CA2243524C Composition and method for producing a salty taste
08/27/2002CA1341386C Acid-labile anchor groups for the synthesis of peptide amides by a solid-phase method
08/22/2002WO2002064549A1 Ppar agonists
08/22/2002WO2002064547A2 Isophthalic acid derivatives as matrix metalloproteinase inhibitors
08/22/2002WO2002064130A1 Proliferative activator receptor (ppar) compounds
08/22/2002WO2002064080A2 Matrix metalloproteinase inhibitors
08/22/2002US20020115881 Microbiocides
08/22/2002US20020115853 6-(3-nitrophenyl)-3H-benzooxazol-2-one for example; contraceptives, treating hormone dependent tumors, endometriosis; progesterone receptor agonists and antagonists
08/22/2002US20020115721 Alkyl carboxy amino acid analogs of glutamic acid; treating neurological, neuropsychological, neuropsychiatric, neurodegenerative, neuropsychopharmacological and functional disorders; postsynaptic glutamate receptor
08/22/2002CA2438551A1 Ppar agonists
08/22/2002CA2438492A1 Proliferative activator receptor (ppar) compounds
08/22/2002CA2437643A1 Matrix metalloproteinase inhibitors
08/22/2002CA2435376A1 Isophthalic acid derivatives as matrix metalloproteinase inhibitors
08/21/2002EP1231914A2 Nordihydroguaiaretic derivatives for use in treatment of tumors
08/20/2002US6437181 Reaction of l-aspartic acid, l-glutamic acid or l-cysteic acid with 1,2-bissulfooxyethane, and/or 1,3,2-dioxathiolane 2,2-dioxide, or 1,3-bissulfooxy-2-hydroxypropane in the presence of a base, and optional subsequent acidification
08/20/2002US6436973 Leukotriene enzyme inhibitors, administered as antiarthritic and antiinflammatory agents; prophylaxis of psoriasis and liver disorders
08/20/2002US6436152 Substituted 2-aminoalky-1,4-diaminobenzene compounds and oxidation dye precursor compositions containing same
08/15/2002WO2002062902A1 Azo dyestuffs
08/15/2002WO2002062871A2 Comonomer compositions for production of imide-containing polyamino acids
08/15/2002WO2002028821A3 Propionic acid derivatives with ppar-alpha activating properties
08/14/2002EP1230210A1 Aminoalcohol derivatives useful for the treatment of gastrointestinal disorders
08/14/2002EP1230209A2 Stable salts of novel derivatives of 3,3-diphenylpropylamines
08/14/2002EP1019362B1 Process for the preparation of stable, non-hygroscopic salts of l(-) carnitine
08/14/2002EP0790974B1 Substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives as matrix metalloprotease inhibitiors
08/14/2002CN1364159A Synthesis of 3-amino-3-aryl propanoates
08/14/2002CN1363552A Preparing process and application of glycerine zinc (CHDNZn)
08/14/2002CN1088992C Topically administrable compositions containing 2-benzoylphenylacetic acid derivatives for treatment of ophthalmic inflammatory disorders
08/13/2002US6433209 Alpha-substitution of unprotected β-amino ester compounds
08/13/2002US6433186 Treatment of conditions where inhibition of thrombin is required (e.g. thrombosis) or as anticoagulants.
08/13/2002US6433014 1-aminocyclopentane-1-carboxylic acid derivative glutamatergic receptor agonists and antagonists; central nervous system disorders; alzheimer*s and parkinson*s disease treatment
08/13/2002CA2214117C Synthesis of bleach activators
08/13/2002CA2167524C Topically administrable compositions containing 3-benzoylphenylacetic acid derivatives for treatment of ophthalmic inflammatory disorders
08/08/2002WO2002060432A1 Hypoglycemic agent
08/08/2002US20020107208 Gabapentin prodrugs and formulations
08/08/2002CA2436425A1 Hypoglycemic agent
08/07/2002EP1229024A1 m-SUBSTITUTED BENZOIC ACID DERIVATIVES EXHIBITING INTEGRIN ALPHA-V BETA-3 ANTAGONISM
08/07/2002EP1229022A1 Process for the preparation of 7-azabicyclo 4.1.0]-hept-3-ene-3-carboxylic acid esters
08/07/2002EP1228061A1 Dipeptidyl peptidase iv inhibitors and methods of making and using dipeptidyl peptidase iv inhibitors
08/07/2002EP1228036A2 Method for producing iminodicarboxylic acids
08/07/2002EP1227721A1 Novel substituted succinic acid metallo-beta-lactamase inhibitors and their use in treating bacterial infections
08/07/2002EP0984922B1 Preparation of tri-iodo benzene compounds
08/07/2002EP0636183B1 Compositions and methods for protein structural determinations
08/07/2002CN1362946A In-situ preparation of polyaspartic ester mixture
08/07/2002CN1362403A Microwave solid-phase synthesis process of amino acid chelate
08/06/2002US6428780 Modified amino acid
08/06/2002CA1341380C Process for the preparation of n-alkylated amino acids and their esters, use in the synthesis of carboxyalkyl dipeptides
08/01/2002WO2002059075A1 Salts of carnitines useful as dietary/nutritional supplements or drugs, processes for preparing same and compositions containing such salts
08/01/2002WO2002058693A1 Metal salts of carnitines useful as dietary/nutritional supplements or drugs and compositions containing such salts
08/01/2002WO2002058680A2 Use of bicylic amino acids for preventing and treating visceral pain and gastrointestinal disorders
08/01/2002WO2001078654A3 Halogentated 2-amino-3, 4 heptenoic acid derivatives useful as nitric oxide synthase inhibitors
08/01/2002WO2001028494A9 Nordihydroguaiaretic derivatives for use in treatment of tumors
08/01/2002WO2001002332A9 Process for the preparation of 3,3-dimethylbutanal
08/01/2002US20020103399 Processes for producing B-halogeno-a-amino-carboxylic acids and phenylcysteine derivatives and intermediates thereof
08/01/2002US20020103398 Double bond acts as a rigidifying element, for unexpected potency and selectivity for inhibition of inducible nitric oxide synthase over the constitutive isoforms
08/01/2002CA2435950A1 Use of bicylic amino acids for preventing and treating visceral pain and gastrointestinal disorders
07/2002
07/31/2002EP1226820A1 Use of bicyclic amino acids for preventing and treating visceral pain and gastrointestinal disorders
07/31/2002EP1226111A1 Chiral (s- or r-methylphenylglycine) amino acid crystal and method for preparing same
07/31/2002EP1226110A1 Bicyclic amino acids as pharmaceutical agents
07/31/2002EP1226109A2 Phenyl amine carboxylic acid compounds and compositions for delivering active agents
07/31/2002EP1226108A1 Diaryl-enynes
07/31/2002EP1226104A1 Phenoxy carboxylic acid compounds and compositions for delivering active agents
07/31/2002EP1225886A2 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits
07/31/2002EP1028938B1 Production of aminohalogencrotonates
07/31/2002EP0719267B1 Second messenger cell signaling inhibitors
07/31/2002CN1361763A Aminobenzophenones as inhibitors of IL-1 beta and TNF_alpha
07/31/2002CN1361098A Prepn of chiral compound L-homophenprobamate and its salt
07/31/2002CN1088454C Synthetic method of electroactive large monomer
07/30/2002US6426424 Heating hydrated metal sulfate salt, an amino acid ligand and a reaction modifier in an enclosed environment, ligand to metal molar ratio is from 1:1-4:1
07/30/2002US6426406 Forming polymorph; using lasers
07/30/2002US6426364 Nervous system or psychological disorders
07/30/2002US6426059 Cascade polymer complexes, process for their production and pharmaceutical agents containing said complexes
07/30/2002CA2291067C Method for the preparation of citalopram
07/25/2002WO2002057218A1 Alanine 2,6-dialkoxyphenyl ester derivatives as hypnotics
07/25/2002WO2002057216A1 Terphenyl compounds bearing substituted amino groups
07/25/2002WO2002057199A1 Process for a homogeneously catalyzed c-c coupling reaction
07/25/2002WO2002056880A1 Triphenylmethane kinesin inhibitors
07/25/2002WO2002040452A3 Production of alkyl 6-aminocaproate
07/25/2002WO2002030947A3 Compositions and methods of preparing amino acid chelates and complexes
07/25/2002WO2001092273A3 Benzenedicarboxylic acid derivatives
07/25/2002US20020099246 Process for preparation of aminocarboxylic acids
07/25/2002US20020098152 Amphipatic polycarboxylic chelates and complexes with paramagnetic metals as MRI contrast agents
07/24/2002EP1224162A1 Mixed-metal chelates and proces for the preparation thereof
07/24/2002EP1224161A1 Nitroxy derivatives of (r) and (s)-carnitine
07/24/2002EP0977726B1 Process for esterification of amino acids and peptides
07/24/2002EP0966425B1 Process for recovering betaine
07/24/2002EP0836485B1 Cascade polymer complexes
07/24/2002CN1360567A Sphingoid base devivs. and uses thereof
07/24/2002CN1360563A Process for preparation of 3,3-dimethylbutanal
07/23/2002US6423866 Production of aminohalogencrotonates
07/23/2002US6423855 Prevention lysis; oxidation resistance
07/18/2002WO2002055480A2 6-substituted indanoyl amino acid conjugates as mimics to the biological activity of coronatine